⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for lkb1

Every month we try and update this database with for lkb1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLCNCT04265534
Non-Small Cell ...
Non-squamous No...
Non-Squamous No...
KEAP1 Gene Muta...
NRF2 Gene Mutat...
NFE2L2 Gene Mut...
Telaglenastat
Carboplatin Che...
Pemetrexed Chem...
Pembrolizumab I...
Placebo
Folic acid 400 ...
Vitamin B12 100...
Dexamethasone 4...
18 Years - Calithera Biosciences, Inc
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsNCT05887492
Non Small Cell ...
Solid Tumors, A...
Endometrial Can...
Pancreatic Canc...
Cervical Cancer
Breast Cancer
Carcinoma of Un...
TNG260
Pembrolizumab
18 Years - Tango Therapeutics, Inc.
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLCNCT04265534
Non-Small Cell ...
Non-squamous No...
Non-Squamous No...
KEAP1 Gene Muta...
NRF2 Gene Mutat...
NFE2L2 Gene Mut...
Telaglenastat
Carboplatin Che...
Pemetrexed Chem...
Pembrolizumab I...
Placebo
Folic acid 400 ...
Vitamin B12 100...
Dexamethasone 4...
18 Years - Calithera Biosciences, Inc
Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsNCT05887492
Non Small Cell ...
Solid Tumors, A...
Endometrial Can...
Pancreatic Canc...
Cervical Cancer
Breast Cancer
Carcinoma of Un...
TNG260
Pembrolizumab
18 Years - Tango Therapeutics, Inc.
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic TumorsNCT06188208
Advanced Solid ...
Advanced Hemato...
VVD-130850
Pembrolizumab
18 Years - Vividion Therapeutics, Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: